Search

Board elections

All members* who have paid their annual fees, have the privilege to influence the composition of the EHA Board. We need your involvement in the selection of EHA’s governmental body.

EHA-SWG Scientific Meeting on Red Cell and Iron Metabolism Defects: From Basic Science to Clinical Case Application

Dates: October 12-14, 2023
Location: Budapest, Hungary
Chairs: A Taher & A Iolascon
Collaborating SWG: EHA Specialized Working Group on Red Cells and Iron

Registration is closed

RegistrationRegistration is closed. Visit this page for more information.

EU commissioner Tonio Borg: 'we will continue to improve the life of people suffering from Thalassaemia'

May 08 2013 Posted in Advocacy news

Today, May 8, is International Thalassemia Day. Today, we seek to enhance the awareness and knowledge of thalassemia and other hemoglobin disorders.

EHA policy on double awarding

EHA is guided by the concept of supporting as many young investigators/clinicians as possible in their career development. Therefore, double awarding is not allowed. Winning an award excludes the award winner from winning another award while receiving the first.

A new targeted combination therapy with potential to eliminate relapsed chronic lymphocytic leukemia

Jun 12 2015 Posted in Press releases

Patients with chronic lymphocytic leukemia (CLL) that has recurred or isn’t responding to standard treatment need new therapies. A new combination of two targeted therapies is showing potential to eliminate CLL in these circumstances.

Mini-hormone fights iron

Jun 14 2013

Iron overload commonly leads to organ damage and even death. Currently available treatments for iron overload are burdensome or cause side effects.